Immunity against the omicron coronavirus variant fades rapidly after a second and third dose of Pfizer and BioNTech’s Covid-19 vaccine, according to peer reviewed research published in JAMA Network Open on Friday, a finding that could support rolling out additional booster shots to vulnerable people as the variant drives an uptick in new cases across the country.
Subscribe
Click here for a secure way to sign up, you will be supporting independent news. Click the button below.
Your Opinions
Disagree with this article? why not write in and you can have your say? email us
